Clinigen signs Africa and Asia distribution agreement with Amgen

Clinigen Group, the global pharmaceutical Products and Services company, has signed a distribution agreement with Amgen to supply part of its product portfolio to multiple countries across Africa and Asia.

Under the terms of the distribution agreement, Clinigen will provide physicians and pharmacists in certain territories with access to medicines which are not currently commercially available.

Clinigen will act as the main point of contact for healthcare professionals wanting to access the medicines, managing all elements of the process including order and enquiry management, regulatory compliance, and logistics. The agreement will help support both companies’ missions of increasing access to medicines for patients across the world.

The following products are included in the agreement:

Sam Herbert, Chief Operating Officer, Clinigen, said: “We are pleased to be partnering with Amgen to supply this portfolio of medicines for patients with unmet medical needs. This agreement will help to ensure healthcare professionals can obtain compliant access to critical medicines that are not commercially available in their country.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Related news